Your browser doesn't support javascript.
loading
Sweet syndrome following the ChAdOx1-S vaccine.
Baker, Olivia; Chen, Kun Sen; Kaminska, Iwona; Rajagopal, Vivek.
Affiliation
  • Baker O; General Medicine, West Suffolk Hospitals NHS Trust, Bury Saint Edmunds, Suffolk, UK olivia.baker4@nhs.net vivek.rajagopal@wsh.nhs.uk.
  • Chen KS; Dermatology, West Suffolk Hospitals NHS Trust, Bury Saint Edmunds, Suffolk, UK.
  • Kaminska I; Pathology, West Suffolk Hospitals NHS Trust, Bury Saint Edmunds, Suffolk, UK.
  • Rajagopal V; General Medicine, West Suffolk Hospitals NHS Trust, Bury Saint Edmunds, Suffolk, UK olivia.baker4@nhs.net vivek.rajagopal@wsh.nhs.uk.
BMJ Case Rep ; 17(1)2024 Jan 12.
Article in En | MEDLINE | ID: mdl-38216167
ABSTRACT
We report a case of vaccine-induced Sweet syndrome in a female patient in her 50s presenting with fevers and a scattered red patchy rash on the lower limbs. Seven days prior, she had received the first dose of AstraZeneca ChAdOx1-S vaccine. A skin biopsy confirmed Sweet syndrome. She did not respond to high doses of prednisolone and required methotrexate therapy to induce remission. This is one of the first reports of Sweet syndrome caused by the ChAdOx1-S vaccine and provides further evidence for vaccine-induced dermatosis. This case demonstrates that methotrexate can induce remission in cases of Sweet syndrome resistant to corticosteroids. This report also describes an approach to the differential diagnosis of patients presenting with a rash, fever and malaise.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sweet Syndrome / Exanthema Type of study: Diagnostic_studies / Etiology_studies Limits: Female / Humans Language: En Journal: BMJ Case Rep Year: 2024 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sweet Syndrome / Exanthema Type of study: Diagnostic_studies / Etiology_studies Limits: Female / Humans Language: En Journal: BMJ Case Rep Year: 2024 Document type: Article